Biohit
2.54 EUR
-0.39 %
4,934 following
Corporate customer
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biohit
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1 | 7.1 | 9.4 | 11.0 | 13.1 | 14.3 | 15.7 | 17.0 | 18.7 | 21.2 | 24.6 |
| growth-% | -29.1 % | 31.4 % | 17.0 % | 19.2 % | 9.8 % | 9.6 % | 8.0 % | 10.1 % | 13.6 % | 16.0 % | |
| EBITDA | 0.6 | -1.2 | 0.5 | 1.6 | 2.1 | 2.9 | 3.4 | 3.1 | 4.6 | 5.1 | 6.2 |
| EBIT (adj.) | -1.4 | -3.2 | -1.5 | 1.1 | 1.8 | 2.5 | 2.9 | 2.6 | 3.0 | 3.3 | 4.2 |
| EBIT | -1.4 | -3.2 | -1.5 | 1.1 | 1.8 | 2.5 | 2.9 | 2.6 | 3.0 | 3.3 | 4.2 |
| Profit before taxes | -1.2 | -3.3 | -1.3 | 0.9 | 2.2 | 2.8 | 2.9 | 2.8 | 3.2 | 3.5 | 4.4 |
| Net income | -1.4 | -3.3 | -1.5 | 0.6 | 1.8 | 2.7 | 2.7 | 2.2 | 2.6 | 2.8 | 3.5 |
| EPS (adj.) | -0.09 | -0.22 | -0.10 | 0.04 | 0.12 | 0.18 | 0.18 | 0.15 | 0.17 | 0.18 | 0.23 |
| growth-% | -134.0 % | 54.8 % | 140.1 % | 189.9 % | 53.1 % | 0.2 % | -17.9 % | 15.1 % | 9.5 % | 25.5 % | |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.05 | 0.06 | 0.12 |
| Dividend ratio | 30.0 % | 30.0 % | 30.0 % | 50.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 5.9 % | -16.5 % | 5.4 % | 14.7 % | 16.1 % | 19.9 % | 21.7 % | 18.4 % | 24.8 % | 24.1 % | 25.0 % |
| EBIT-% (adj.) | -14.0 % | -44.6 % | -15.8 % | 10.3 % | 13.4 % | 17.1 % | 18.5 % | 15.4 % | 16.0 % | 15.5 % | 17.0 % |
| EBIT-% | -14.0 % | -44.6 % | -15.8 % | 10.3 % | 13.4 % | 17.1 % | 18.5 % | 15.4 % | 16.0 % | 15.5 % | 17.0 % |
| ROE | -28.3 % | -18.5 % | 8.0 % | 20.6 % | 24.7 % | 19.8 % | 13.7 % | 14.0 % | 13.9 % | 15.6 % | |
| ROI | -25.9 % | -17.7 % | 14.3 % | 19.1 % | 23.5 % | 18.2 % | 16.1 % | 17.5 % | 17.3 % | 19.5 % |